{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T23:34:44Z","timestamp":1761953684242,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1983,6,1]],"date-time":"1983-06-01T00:00:00Z","timestamp":423273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1983,6,1]],"date-time":"1983-06-01T00:00:00Z","timestamp":423273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1983,6]]},"DOI":"10.1136\/ard.42.3.308","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"308-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intermediate-dose intramuscular methylprednisolone acetate in the treatment of rheumatic disease."],"prefix":"10.1016","volume":"42","author":[{"given":"J","family":"Kovarsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0002-9343(81)90538-6","article-title":"High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus","volume":"70","author":"P, Kimberly R.; D, Lockshin M.; L, Sherman R.","year":"1981","unstructured":"Kimberly R P, Lockshin M D, Sherman R L, et al. High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus. Am J Med 1981; 70: 817-24.","journal-title":"Am J Med"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-94-1-21","article-title":"Pulse methylprednisolone in rheumatoid arthritis: a double-blind cross-over trial","volume":"94","author":"R, Liebling M.; E, Leib; K, Mclaughlink B.","year":"1981","unstructured":"Liebling M R, Leib E, Mclaughlink B K, et al. Pulse methylprednisolone in rheumatoid arthritis: a double-blind cross-over trial. Ann Intern Med 1981; 94: 21-6.","journal-title":"Ann Intern Med"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/art.1780240521","article-title":"Intravenous methylprednisolone pulse therapy in severe ankylosing spondylitis","volume":"24","author":"Mintz, G.; D, Enriquez R.; Mercado, U.","year":"1981","unstructured":"Mintz G, Enriquez R D, Mercado U, et al. Intravenous methylprednisolone pulse therapy in severe ankylosing spondylitis. Arthritis Rheum 1981; 24: 734-6.","journal-title":"Arthritis Rheum"},{"key":"ref_4","first-page":"677","article-title":"Complications of methylprednisolone pulse therapy","volume":"23","author":"Garrett, R.; Paulus, H.","year":"1980","unstructured":"Garrett R, Paulus H. Complications of methylprednisolone pulse therapy. Arthritis Rheum 1980; 23: 677.","journal-title":"Arthritis Rheum"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.7326\/0003-4819-95-1-122_1","article-title":"Sudden death after methylprednisolone pulse therapy","volume":"95","author":"Bocanegra T S, Castaneda M 0, Espinoza L R","year":"1981","unstructured":"Bocanegra T S, Castaneda M 0, Espinoza L R, et al. Sudden death after methylprednisolone pulse therapy. Ann Intern Med 1981; 95:-122.","journal-title":"Ann Intern Med"},{"key":"ref_6","first-page":"1145","article-title":"Intravenous methylprednisolone sodium succinate: adverse reactions reported in association with","volume-title":"immunosuppressive therapy. Transplant Proc 1973; 5","author":"S, Stubbs S.; M, Morell R.","unstructured":"Stubbs S S, Morell R M. Intravenous methylprednisolone sodium succinate: adverse reactions reported in association with immunosuppressive therapy. Transplant Proc 1973; 5: 1145-6."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.7326\/0003-4819-94-1-128","article-title":"Pulse therapy in rheumatoid arthritis","volume":"94","author":"V, Hess E.; L, Kammen P.","year":"1981","unstructured":"Hess E V, Kammen P L. Pulse therapy in rheumatoid arthritis. Ann Intern Med 1981; 94: 128-9.","journal-title":"Ann Intern Med"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/jama.1981.03310310049024","article-title":"Anaphylaxis after intravenous methylprednisolone administration","volume":"245","author":"D, Freedman M.; L, Schocket A.; N, Chapel; G, Gerber J.","year":"1981","unstructured":"Freedman M D, Schocket A L, Chapel N, Gerber J G. Anaphylaxis after intravenous methylprednisolone administration. JAMA 1981; 245: 607-8.","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/art.1780241012","article-title":"Preliminary criteria for clinical remission in rheumatoid arthritis","volume":"24","author":"S, Pinals R.; T, Masi A.; A, Larsen R.","year":"1981","unstructured":"Pinals R S, Masi A T, Larsen R A, et al. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981; 24: 1308-15.","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672413539X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672413539X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.42.3.308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T06:19:49Z","timestamp":1737526789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672413539X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,6]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1983,6]]}},"alternative-id":["S000349672413539X"],"URL":"https:\/\/doi.org\/10.1136\/ard.42.3.308","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[1983,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intermediate-dose intramuscular methylprednisolone acetate in the treatment of rheumatic disease.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.42.3.308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1983 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}